Joe Betts-LaCroix

Joe Betts-LaCroix is a multifaceted scientist and entrepreneur known for his innovative work in biotechnology. As the CEO of Retro Biosciences, a company supported by OpenAI's Sam Altman, he leads efforts to develop groundbreaking therapies aimed at reversing aging processes. Betts-LaCroix is particularly focused on the experimental drug RTR242, which seeks to rejuvenate cellular processes linked to neurodegenerative diseases like Alzheimer's. His previous accomplishments include creating one of the world's smallest computers, showcasing his commitment to pushing the boundaries of technology and science.